Literature DB >> 15388455

Mechanism of resistance to several antimicrobial agents in Salmonella Clinical isolates causing traveler's diarrhea.

Roberto Cabrera1, Joaquím Ruiz, Francesc Marco, Inés Oliveira, Margarita Arroyo, Ana Aladueña, Miguel A Usera, M Teresa Jiménez De Anta, Joaquím Gascón, Jordi Vila.   

Abstract

The evolution of antimicrobial resistance in Salmonella isolates causing traveler's diarrhea (TD) and their mechanisms of resistance to several antimicrobial agents were analyzed. From 1995 to 2002, a total of 62 Salmonella strains were isolated from stools of patients with TD. The antimicrobial susceptibility to 12 antibiotics was determined, and the molecular mechanisms of resistance to several of them were detected as well. The highest levels of resistance were found against tetracycline and ampicillin (21 and 19%, respectively), followed by resistance to nalidixic acid (16%), which was mainly detected from 2000 onward. Molecular mechanisms of resistance were analyzed in 16 isolates. In these isolates, which were resistant to ampicillin, two genes encoding beta-lactamases were detected: oxa-1 (one isolate) and tem-like (seven isolates [in one strain concomitantly with a carb-2]). Resistance to tetracycline was mainly related to tetA (five cases) and to tetB and tetG (one case each). Resistance to chloramphenicol was related to the presence of the floR and cmlA genes and to chloramphenicol acetyltransferase activity in one case each. Different genes encoding dihydrofolate-reductases (dfrA1, dfrA12, dfrA14, and dfrA17) were detected in trimethoprim-resistant isolates. Resistance to nalidixic acid was related to the presence of mutations in the amino acid codons 83 or 87 of the gyrA gene. Further surveillance of the Salmonella spp. causing TD is needed to detect trends in their resistance to antimicrobial agents, as we have shown in our study with nalidixic acid. Moreover, such studies will lead to better treatment and strategies to prevent and limit their spread.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15388455      PMCID: PMC521922          DOI: 10.1128/AAC.48.10.3934-3939.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  39 in total

1.  Nalidixic acid-resistant Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin caused treatment failure: a report from Bangladesh.

Authors:  S M Zahurul Haque Asna; J Ashraful Haq; Md Mushfequr Rahman
Journal:  Jpn J Infect Dis       Date:  2003-02       Impact factor: 1.362

2.  Increase in incidence of resistance to ampicillin, chloramphenicol and trimethoprim in clinical isolates of Salmonella serotype Typhimurium with investigation of molecular epidemiology and mechanisms of resistance.

Authors:  F Gallardo; J Ruiz; F Marco; K J Towner; J Vila
Journal:  J Med Microbiol       Date:  1999-04       Impact factor: 2.472

3.  Evolution of multiresistance in nontyphoid salmonella serovars from 1984 to 1998 in Argentina.

Authors:  Betina E Orman; Silvia A Piñeiro; Sonia Arduino; Marcelo Galas; Roberto Melano; Maria I Caffer; Daniel O Sordelli; Daniela Centrón
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

4.  Clinical presentation of non-typhoidal Salmonella bacteraemia in Malawian children.

Authors:  S M Graham; A L Walsh; E M Molyneux; A J Phiri; M E Molyneux
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 May-Jun       Impact factor: 2.184

5.  Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years.

Authors:  C W Hoge; J M Gambel; A Srijan; C Pitarangsi; P Echeverria
Journal:  Clin Infect Dis       Date:  1998-02       Impact factor: 9.079

6.  Antimicrobial resistance of Shigella isolates causing traveler's diarrhea.

Authors:  J Vila; J Gascon; S Abdalla; J Gomez; F Marco; A Moreno; M Corachan; T Jimenez de Anta
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

7.  Fitness cost of fluoroquinolone resistance in Salmonella enterica serovar Typhimurium.

Authors:  Etienne Giraud; Axel Cloeckaert; Sylvie Baucheron; Christian Mouline; Elisabeth Chaslus-Dancla
Journal:  J Med Microbiol       Date:  2003-08       Impact factor: 2.472

8.  Life-threatening infantile diarrhea from fluoroquinolone-resistant Salmonella enterica typhimurium with mutations in both gyrA and parC.

Authors:  Hideo Nakaya; Akihiro Yasuhara; Ken Yoshimura; Yukio Oshihoi; Hidemasa Izumiya; Haruo Watanabe
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

9.  The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar typhimurium phage type DT204.

Authors:  Sylvie Baucheron; Hein Imberechts; Elisabeth Chaslus-Dancla; Axel Cloeckaert
Journal:  Microb Drug Resist       Date:  2002       Impact factor: 3.431

10.  Comparative antibiotic resistance of diarrheal pathogens from Vietnam and Thailand, 1996-1999.

Authors:  Daniel W Isenbarger; Charles W Hoge; Apichai Srijan; Chittima Pitarangsi; Niyada Vithayasai; Ladaporn Bodhidatta; Kimberly W Hickey; Phung Dac Cam
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

View more
  17 in total

1.  Class 1 Integrons in Salmonella Strains causing traveler's diarrhea.

Authors:  Roberto Cabrera; Francesc Marco; Jordi Vila; Joaquím Ruiz; Joaquím Gascón
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

2.  Gene cassette encoding a 3-N-aminoglycoside acetyltransferase in a chromosomal integron.

Authors:  Liam D H Elbourne; Ruth M Hall
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

3.  Antimicrobial resistance genes associated with Salmonella enterica serovar newport isolates from food animals.

Authors:  Aaron M Lynne; Bobbie S Rhodes-Clark; Kimberly Bliven; Shaohua Zhao; Steven L Foley
Journal:  Antimicrob Agents Chemother       Date:  2007-10-29       Impact factor: 5.191

4.  Antibiotic resistance pattern among the Salmonella isolated from human, animal and meat in India.

Authors:  Shweta Singh; Rajesh Kumar Agarwal; Suresh C Tiwari; Himanshu Singh
Journal:  Trop Anim Health Prod       Date:  2011-08-20       Impact factor: 1.559

5.  Virulence factors and mechanisms of antimicrobial resistance in Shigella strains from periurban areas of Lima (Peru).

Authors:  Angela Lluque; Susan Mosquito; Cláudia Gomes; Maribel Riveros; David Durand; Drake H Tilley; María Bernal; Ana Prada; Theresa J Ochoa; Joaquim Ruiz
Journal:  Int J Med Microbiol       Date:  2015-05-04       Impact factor: 3.473

Review 6.  Carrion's Disease: the Sound of Silence.

Authors:  Cláudia Gomes; Joaquim Ruiz
Journal:  Clin Microbiol Rev       Date:  2017-11-29       Impact factor: 26.132

Review 7.  Transferable Mechanisms of Quinolone Resistance from 1998 Onward.

Authors:  Joaquim Ruiz
Journal:  Clin Microbiol Rev       Date:  2019-08-14       Impact factor: 26.132

8.  SGI1-K, a variant of the SGI1 genomic island carrying a mercury resistance region, in Salmonella enterica serovar Kentucky.

Authors:  Renee S Levings; Sally R Partridge; Steven P Djordjevic; Ruth M Hall
Journal:  Antimicrob Agents Chemother       Date:  2006-11-06       Impact factor: 5.191

9.  Antimicrobial susceptibility and mechanisms of resistance in Shigella and Salmonella isolates from children under five years of age with diarrhea in rural Mozambique.

Authors:  Inácio Mandomando; Dinis Jaintilal; Maria J Pons; Xavier Vallès; Mateu Espasa; Laura Mensa; Betuel Sigaúque; Sergi Sanz; Jahit Sacarlal; Eusébio Macete; Fátima Abacassamo; Pedro L Alonso; Joaquim Ruiz
Journal:  Antimicrob Agents Chemother       Date:  2009-03-30       Impact factor: 5.191

10.  Klebsiella spp. cause severe and fatal disease in Mozambican children: antimicrobial resistance profile and molecular characterization.

Authors:  Arsénia J Massinga; Marcelino Garrine; Augusto Messa; Nélio A Nobela; Nadia Boisen; Sergio Massora; Anélsio Cossa; Rosauro Varo; António Sitoe; Juan Carlos Hurtado; Jaume Ordi; Hélio Mucavele; Tacilta Nhampossa; Robert F Breiman; Cynthia G Whitney; Dianna M Blau; Quique Bassat; Inácio Mandomando
Journal:  BMC Infect Dis       Date:  2021-06-05       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.